Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor

NCT03017053 is registered in ClinicalTrials.gov with Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University as lead sponsor.

NCT NCT03017053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03017053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor
Lead sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2016
Completion date
July 31, 2025
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral cancer